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Abstract Background: Unilateral total knee replacement (TKR) can result in
a substantial blood loss and 30e50% of these patients receive allogeneic blood
transfusion (ABT), this transfusion rate may be even higher among anaemic
patients.
Patients and methods: We assessed the requirements for ABT in 156 consecutive pa-
tients undergoing surgery for primary TKR, who received iron ferrous sulphate
(256 mg/day; 80 mg of Fe2þ), vitamin C (1000 mg/day) and folic acid (5 mg/day) dur-
ing the 30e45 days preceding surgery, and who were transfused if Hb <80
g/L and/or clinical signs/symptoms of acute anaemia/hypoxemia (Group 2). A pre-
vious series of 156 TKR patients serves as a control group (Group 1).
Results: Compared to those in Group 1, patients in Group 2 presented a lower trans-
fusion rate (5.8% vs. 32%, for Group 2 and Group 1, respectively; p < 0.01), and
a lower transfusion index (1.78  0.44 vs. 2.22  0.65 units per transfused patient,
respectively; p < 0.05). After patient’s stratification according to a preoperative Hb
above or below 130 g/L, the differences in transfusion rate remained significant,
although 19% of patients from Group 2 still needed ABT if their preoperative Hb
<130 g/L.
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TKR patients, whereas for anaemic patients another blood saving strategy, such us
preoperative erythropoietin administration or postoperative blood salvage, should
be added to further increase its effectiveness.
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Unilateral total knee replacement (TKR) can result
in a substantial blood loss1,2 and 20e50% of these
patients receive allogeneic blood transfusion
(ABT).2e4 However, allogeneic blood is a scarce
and increasingly expensive resource and ABT is
not a risk free therapy for orthopaedic patients.2,3
All these have prompted the development of dif-
ferent methods to reduce or avoid ABT in these
patients, including implementation of restrictive
transfusion protocols,5 use of postoperative auto-
transfusion1,6,7 and administration of pharmaco-
logical agents.8
On the one hand, a recent meta-analysis of
randomised clinical trials concluded that preoper-
ative autologous blood donation (PABD) (RR 0.16;
95%CI 0.07e0.36) and perioperative cell salvage
(RR 0.35; 95%CI 0.21e0.52) decrease the fre-
quency of exposures to ABT when compared with
a control in orthopaedic surgery.9 However, the
real contribution of autologous blood to ABT reduc-
tion decreases if a transfusion protocol is adop-
ted.9 From these data it can be inferred that
a transfusion protocol does in itself reduce by
25e30% the relative risk for ABT and, therefore,
it must be the first strategy to include in a blood
saving program. on the other hand, it is well known
that preoperative Hb level is one of the strongest
predictors for postoperative ABT after TKR,4,10,11
and that stimulation of erythrocyte production
may reduce the requirements for ABT in patients
with mild anaemia.8
In this work, we therefore evaluated the effec-
tiveness of the implementation of a restrictive
transfusion protocol together with the preoperative
administration of haematinics to reduce the re-
quirements for ABT in patients undergoing surgery
for TKR, with special interest on those patients with
mild anaemia (Hb <130 g/L).
Patients and methods
Patients
After approval by the Institutional Review Board,
during a 12 month period, all patients scheduled for
elective primary TKR in a single institution wereinterviewed by the surgeon at least 1 month before
surgery to enter in a blood saving protocol. Patients
with haematological diseases or coagulation disor-
ders, those under anticoagulant therapy or with
known infection or malignancy at admission and
those with revision surgery or preoperative autolo-
gous blood donation were excluded. Finally, 156
TKR patients entered the study (Group 2). A previ-
ous series of another 156 TKR patients who met
these inclusion criteria and underwent surgery be-
fore the implementation of the blood saving proto-
col, served as the control group (Group 1).
Data collection
A set of demographical and clinical data was
gathered for all patients, including gender, age,
preoperative Hb concentration at the time of
surgeon’s interview, 24 h postoperative Hb con-
centration, transfusion rate (percentage of trans-
fused patients), transfused units, transfusion
index (blood units per transfused patient), and
length of hospital stay.
Surgical procedure
All patients were operated on by the same surgical
team, under standardised anaesthesia, antibiotic
and antithrombotic prophylaxis, and postoperative
analgesia. The same implant (Nex-Gen, Zimmer,
USA) was used in all knees, with all components
being cemented. All procedures were performed
using a pneumatic tourniquet that was deflated
after wound closure, and three closed suction drains
(two inside the joint and one subcutaneous), which
were removed at the second postoperative day. All
patients stayed at the post-anaesthesia recovery
unit for at least 2 h before being transferred to
the ward.
Blood saving protocol
In Group 2, patients received iron ferrous sulphate
(256 mg/day; 80 mg of Fe2þ), vitamin C (1000
mg/day) and folic acid (5 mg/day) during the
30e45 days preceding surgery, and referred
adverse effects of the treatment were recorded.
Normovolaemic patients were transfused if their
Hb felt below 80 g/L and presented clinical signs/
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sion, tachycardia, tachypnea, dizziness, fatigue,
etc.) or at a higher Hb if they presented clinical signs
and were at risk (e.g., coronary or valve heart dis-
ease or obstructive pulmonary disease). In the con-
trol group, patients did not received preoperative
haematinics and transfusion decisions relied only
in a Hb level below 90 g/L. All patients received
oxygen therapy (2 L/min) during the first 48 postop-
erative hours. No other blood saving method was
used in any patient.
Statistical analysis
Data were expressed as percentage (%) or as the
mean  SD (n). Pearson’s chi-squared test or Fish-
er’s exact test was used for comparison of qualita-
tive variables, and Student’s t test, ManneWhitney
U test or Wilcoxon’s rank test for comparison of
quantitative variables. All statistics were per-
formed with SPSS 11.0 (licensed to the University
of Ma´laga, Spain) and a p value <0.05 was consid-
ered statistically significant.
Results
There were not statistically significant differences
between groups regarding patient’s age, gender
distribution, anaesthetic risk (ASA I-III), Hb at
preoperative assessment, or length of hospital
stay (Table 1). At preoperative assessment, 17%
of patients in Group 1 (26/156; 24 women and 2
men), and 20% of patients in Group 2 (31/156; 25
women and 6 men) presented a Hb level lower
than 130 g/L (p ¼ NS).
When compared to Group 1, this blood saving
protocol resulted in a lower percentage of
transfused patients (5.8% vs. 32%, for Group 2
and Group 1, respectively; chi-squared ¼ 35.1,
p < 0.01) and no serious adverse effects of haema-
tinic administration was reported by the patients.
In Group 1, 15 patients received transfusion on the
second postoperative day or later, whereas in
Group 2 all transfusions were given with the first
24 postoperative hours. The differences in trans-
fusion rate remained significant after patient’s
stratification according to preoperative Hb: 19.3
vs. 61.5% for Hb <130 g/L (chi-squared ¼ 10.6,
p < 0.01), and 2.4 vs. 26.1% for Hb 130 g/L
(chi-squared ¼ 28.9, p < 0.001), for Group 2 and
Group 1, respectively (Fig. 1). Similarly, a lower
transfusion index was recorded for Group 2 when
compared to Group 1 (Table 1). After patient’s
stratification according to preoperative Hb, these
differences remained significant only for patientswith Hb 130 g/L (p < 0.05) (Fig. 1). Finally, as
shown in Table 1, 24 h postoperative Hb levels
were significantly higher in Group 2 with respect
to Group 1 (t ¼ 2.06, p < 0.05), and this differ-
ence was even higher after subtracting the effect
of transfusions given within the first 24 postopera-
tive hours (100  14 vs. 107  16 g/L, for Group 1
and 2, respectively; t ¼ 4.73, p < 0.01).
Discussion
Allogeneic blood transfusions are often necessary
during and after total hip and total knee arthro-
plasty because of perioperative blood loss-induced
anaemia. However, the rate of postoperative in-
fection is significantly higher in receiving ABT than
in those receiving autologous blood or in those
non-transfused, most probably due to a transfu-
sion-related immuno-depression.2,3 In addition,
there are ABT-related risks, such as transfusion
Table 1 Demographic and clinical data of two
series of patients undergoing surgery for total knee
replacement with (Group 2) or without (Group 1,
control) preoperative oral haematinic supplements
(ferrous sulphate, 240 mg/day; vitamin C, 1000 mg/
day; and folic acid, 5 mg/day, for 30e45 days prior
to surgery) and restrictive transfusion protocol
Group 1a Group 2b
Patients (n) 156 156
Age (years) 70  5 71  6
Gender (M/F) 48/108 53/103
Preoperative Hb
(g/L)
139  13 141  13
24 h postoperative
Hb (g/L)
105  12 108  14*
Transfused patients
(n, %)
50 (32) 9 (5.8)**
Transfused units (n, %)
0 110 (68) 147 (94.2)
1 3 (2) 2 (1.3)
2 36 (23) 7 (4.5)*
3 11 (7) 0 (0)
Transfusion index
(units/ transfused
patient)
2.22  0.65 1.78  0.44***
Length of hospital
stay (days)
12  4 11  5
Data are expressed as mean  SD, incidence or %. *t ¼ 2.06,
p < 0.05, Group 1 vs. Group 2; **chi-squared ¼ 35.1, p <0.01,
Group 1 vs. Group 2; ***W ¼ 191.5, p < 0.05, Group 1 vs.
Group 2.
a Transfusion protocol: Hb <90 g/L.
b Transfusion protocol: Hb <80 g/L and/or signs/symptoms
of acute anaemia/hypoxemia.
92 J. Cuenca et al.reactions through storage-induced mechanisms,
errors in blood administration and viral or bacterial
contamination, which have led to the development
of different strategies to reduce or avoid the need
for ABT.
The fundamental appreciation that transfusion
threshold is one of the most significant determi-
nants of transfusion seems to have been lost in the
clinical setting, and as a result we are probably
overusing blood transfusion after elective joint
replacement.5 In this respect, a randomised trial
in critically ill patients found that a restrictive
transfusion threshold (Hb <70 g/L) was as safe as
a liberal transfusion threshold (Hb <100 g/L).12
However, a higher transfusion threshold seems
more appropriate for surgical patients with no
risk factors for ischaemia, as they have a much
lower degree of monitoring. In addition, attention
needs to be paid to signs and symptoms of
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Figure 1 Allogeneic transfusion in patients undergoing
primary total knee arthroplasty, according to the preoper-
ative haemoglobin level. (A) Percentage of transfused
patients (*chi-squared ¼ 10.6, p < 0.01, **chi-squared ¼
28.9, p < 0.01, group 1 vs. group 2). (B) Transfusion index
(units per transfused patient) (***W ¼ 24, p < 0.05, group
1 vs. group 2).anaemia, as they are variable depending on the
patient’s age, body temperature, medications,
rate of volume loss and co-morbidities.
As of January 2000, a conservative transfusion
protocol (Hb threshold 90 g/L) was introduced in
our institution. Patients in the control group
(Group 1) were managed with this conservative
transfusion protocol resulting in 32% of patients
being transfused and in a transfusion index of
2.22 units per transfused patient. To reduce these
figures, we implemented a blood saving protocol
for TKR in which in a more restrictive transfusion
protocol (Hb <80 g/L) was the cornerstone. Addi-
tionally, all patients received oral haematinics
for 30e45 days prior to surgery to improve erythro-
poiesis, as low iron stores and folate deficiency are
not uncommon among elderly patients.13,14 This
protocol has proved to be useful since the transfu-
sion rate (5.8%) and the transfusion index (1.78
units per transfused patient) in patients from
Group 2 were reduced with respect to both the
previous series in our institution (Group 1) and
other published series.2e6 Moreover, for patients
with preoperative Hb <130 g/L, our protocol
seems to be as effective as other more complex
and expensive protocols, involving the use of
rHuEPO alone or in combination with other blood
conservation methods, or a flow chart on the use
of blood transfusion, with a lower transfusion trig-
ger (Hb <70 g/L).15e18
This greater effectiveness is probably due to the
stimulatory effect of haematinics on erythropoie-
sis,19 although part of the observed effect could
reflect changes in the general attitude towards al-
logeneic transfusion. In this regard, a randomised
trial on iron pre-load for major joint replacement
showed that at least 18% of patients attending
for hip or knee replacement were anaemic and
benefited significantly from preoperative iron sup-
plements over 4 weeks.13 In addition, iron supple-
mentation in patients without obvious anaemia
protects against a fall in Hb during the immediate
post-operative period, suggesting a widespread
underlying depletion of iron stores in this group de-
spite a normal Hb.13 However, when administered
after surgery, oral iron was not effective in rising
Hb levels20,21 since post-operative erythropoiesis
is limited by the inflammatory effects of surgery
on iron metabolism.22,23 On the other hand, a pop-
ulation-based study (n ¼ 1562) of older persons re-
vealed that up to 20% of them were at high risk of
folate deficiency and, consequently, they should
be considered for treatment.14
The stimulatory effect of preoperative haema-
tinics may also be inferred from comparison of
data obtained both groups. As shown in Table 1,
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operative Hb at the time of surgeon’s interview,
but at 24 h postoperative Hb was significantly
higher in Group 2. However, the transfusion index
was higher in Group 1 than in Group 2 (Table 1),
and it can be assumed that transfusion of one
packet red cell unit increases patient’s Hb by
10 g/L and that perioperative blood loss was simi-
lar in both series. Thus, by subtracting the effect
of transfusion given within the first 24 postopera-
tive hours, the preoperative treatment would ac-
count for a reduction in postoperative Hb drop of
about 7 g/L (100  14 vs. 107  16 g/L, for Groups
1 and 2, respectively; p < 0.01).This effect seems
to be important as 15 patients from Group 1 re-
ceived transfusion on the second postoperative
day or later, whereas all patients in Group 1 where
transfused within the first 24 h postoperative
hours. In addition, the differences in transfusion
rate would have been remained if the same trans-
fusion threshold (Hb <90 g/L) would have been
used in both groups (32 vs. 12%, for Groups 1 and
2, respectively; p < 0.01). Hence, in contrast to
postoperative oral iron,20,21 preoperative haema-
tinic supplements including oral iron may enhance
erythropoiesis13 and, within a coordinated blood
saving strategy, it may help to reduce postopera-
tive transfusion requirements.19
In conclusion, this blood saving protocol seems
to be effective for reducing ABT in TKR patients,
although the limitations derived from study design
preclude establishing whether this is due to the
use of oral haematinics or a more reluctant trans-
fusion protocol. Despite this, we believe that the
use of a restrictive transfusion threshold might
contribute to an early ABT reduction (<48 h),
whereas the stimulatory effect of perioperative
administration of haematics on erythropoiesis
might contribute to avoiding late ABT (>72 h). In
addition, the use of intravenous iron might also
be considered for those patients who do not toler-
ate oral iron and when time to surgery is too short
for oral therapy.24,25 Finally, since 19% of the anae-
mic TKR patients still needs ABT, it becomes evi-
dent that some additional blood saving method,
such us postoperative blood salvage1,6 or preoper-
ative administration of recombinant human eryth-
ropoietin,26 should be associated to reduce further
the need for ABT.
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